
In this interview, Dr. Jeffrey Gladden and a co‑speaker discuss the emerging "anabolic era" in sports medicine and arthritis treatment. They explain that modern practice moves beyond merely repairing damaged tissue; it now adds biologic anabolics—such as platelet‑rich plasma (PRP), bone‑marrow aspirate, autologous fat, mesenchymal stem cells, and various birth‑tissue products—to stimulate the body’s own healing cascade of endogenous peptides and stem cells. These growth‑factor‑rich substances are intended to accelerate tissue repair, especially for high‑profile injuries like anterior cruciate ligament (ACL) tears and Achilles ruptures, which traditionally require up to a year of recovery. The conversation highlights how these anabolics are being incorporated into cartilage regeneration protocols to shorten healing times and improve outcomes.










